Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.
Am. J. Pathol., Jun;174(6):2347-56 (2009)
Trabectedin: an anticancer drug from the sea.
Expert Opin Pharmacother., Nov;10(16):2735-43 (2009)
New developments in targeted therapy for soft tissue sarcoma.
Curr Oncol Rep., Jul;12(4):261-5 (2010)
Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.
Leuk. Lymphoma., Jun;47(6):998-1005 (2006)
The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients.
J. Cancer Res. Clin. Oncol., Mar;134(3):381-7 (2008)
Review of erlotinib in the treatment of advanced non-small cell lung cancer.
Biologics., Dec;1(4):335-46 (2007)
Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma.
J. Clin. Oncol., Nov;17(11):3457-60 (1999)
Lung cancer presenting with solitary bone metastases. Case 1: metastatic adenocarcinoma to the patella.
J. Clin. Oncol., Sep;17(9):2995-7 (1999)
Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors.
Cancer., Mar;88(5):1051-6 (2000)
Germ cell tumor associated primitive neuroectodermal tumors.
J. Urol., May;165(5):1514-6 (2001)
Antiangiogenesis agents in the treatment of soft tissue sarcomas
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors
Journal of the National Comprehensive Cancer Network
New developments in targeted therapy for soft tissue sarcoma
The Predictive Value of Tumor associated macrophages in leiomyosarcoma
American Journal of Clinical Oncology
Trabectedin: an anticancer drug from the sea
Expert Opinions in Pharmacotherapy